-
FDA approved the first targeted drug for common lung cancer mutations
Time of Update: 2021-08-12
regulatory agencies have approved the first drug to treat patients with the most common type of lung cancer, whose tumors have genetic mutations that have long been considered untreated with drugs .
-
Nature Sub-Journal: Cells construct biomedical active composite polymers
Time of Update: 2021-08-12
The traditional method of making sipn usually involves producing components called monomers and mixing them together under appropriate chemical conditions to control their assembly into a large network in one process, said You Lingchong, professor of biomedical engineering at Duke University: "When it works, it is a wonderful platform that can integrate different functions into self-assembled layers for biomedical or environmental applications .
-
Oxford Nanopore Technologies Ultra-long DNA Sequencing Kit
Time of Update: 2021-08-12
Oxford Nanopore Technologies has released a new ultra-long DNA sequencing kit for use in combination with Circulomics' Nanobind kit .
This transposition-based kit maximizes the number of ultra-long reads, enabling continuous sequencing of a single DNA fragment up to 4.
Request more information about Apogee ultra-sensitive nano flow cytometer now
-
Apparent Biology was authorized by the Chinese Academy of Sciences for the transformation of Nature-level RIC-seq technical achievements
Time of Update: 2021-08-12
The transformation application of RIC-seq technology will further enrich the product line of epibiology in the field of medical epigenetics, and will be carried out together with HiChIP technology (DNA-DNA interaction) and RADICL-seq technology (RNA-DNA interaction) The innovative combination strongly promotes the development of domestic biomedical research to a higher dimension and deeper level, and serves the national "Healthy China" grand strategy .
-
The Fifth China Biologics CMC International Summit|BioCMC Summit
Time of Update: 2021-08-12
com Summit official website: http:// For more conference information, scan the QR code to follow" Medical leader"Best Media｜Best Media is committed to building itself into a comprehensive industry service platform in the field of life sciences, promoting industry progress by holding industry summits and training in various sub-fields, and also providing professionals in the industry with a professional online learning platform .
-
Research funding of 45 million!
Time of Update: 2021-08-12
On May 14, 2021, the launching ceremony of the "Innovation Research Institute Establishment and Academician Expert Workstation Unveiling" organized by Shanghai Zhongke New Life Biotechnology Co. , Ltd
-
"First-in-class" oral diabetes therapy approved in Japan
Time of Update: 2021-08-11
The randomized, double-blind, placebo-controlled TIMES 3 trial lasted 16 weeks, including a 36-week open-label extension period, and evaluated the efficacy and safety of Twymeeg in combination with insulin in patients with type 2 diabetes who had poor blood glucose control and received insulin therapy .
-
Nano "antenna" array realizes real-time dynamic force imaging of cardiomyocytes
Time of Update: 2021-08-11
In response to this challenge, the collaborative research team proposed a method for real-time measurement of the force distribution of living cells with ultra-high spatial resolution based on the effect of piezoelectric optoelectronics .
-
QIAGEN won the "2021 Outstanding Word-of-mouth Employer" award
Time of Update: 2021-08-11
Adhering to the fine traditions of QIAGEN and striving to establish a highly adaptable corporate culture of multinational companies, QIAGEN implements key strategies for effectiveness from three aspects: three "focused" human resource strategies to promote employees Self-realization; shaping an efficient, healthy, and highly-participated corporate culture; actively carrying out multiple public welfare activities and fulfilling corporate social responsibilities .
-
Under the three-child policy, how can assisted reproductive technology achieve "a good pregnancy comes naturally"?
Time of Update: 2021-08-11
PGT-A technology can detect chromosome aneuploidy and chromosome copy number variation on pre-implantation embryo cells, and select embryos with normal chromosome number, which can effectively improve the success rate of in vitro fertilization and help the popularization and application of assisted reproductive technology .
-
China officially obtains malaria elimination certification, WHO: a remarkable feat
Time of Update: 2021-08-10
On June 30, the World Health Organization issued a press release stating that China has officially obtained the WHO malaria elimination certification .
-
Highlights of the PMIO 2021 summit, focusing on CGT, targeted new drug & antibody drug development, the precision drug developer conference you must pay attention to
Time of Update: 2021-08-10
How will we seize new opportunities in the new changes, and what new expectations will be filled in 2022?On August 20-21, 2021, the 4th China Precision Medicine and Tumor Immunotherapy Summit of PMIO 2021 kicked off in Zhangjiang, Shanghai, inviting more than 600 leaders and decision makers from Top-level well-known/multinational pharmaceutical companies in the industry.
-
New research pushes new gene therapy for heart failure to the clinic
Time of Update: 2021-08-10
Early work in Martin's laboratory showed that closing the hippo signaling pathway in a mouse model that mimics human advanced heart failure will cause the mouse heart to restore its pumping function .
-
The lung cancer targeted drug independently developed by Chinese experts for 5 years was approved for marketing
Time of Update: 2021-08-10
Professor Lu Shun, director of the Oncology Department of Shanghai Chest Hospital , told reporters that Saivotinib will bring long-term survival hope to patients with non-small cell lung cancer with skip mutations in MET exon 14 .
-
Sutaida® is approved for listing in China to benefit more patients with neuroendocrine tumors
Time of Update: 2021-08-10
Sofatinib (Sutaida®) was officially approved by the China National Medical Products Administration ("SFDA") for the treatment of advanced pancreatic neuroendocrine tumors (pNETs) .
Previously, Sofatinib was approved in China for the treatment of advanced non-pancreatic neuroendocrine tumors (epNETs) .
-
AbbVie Rinvoq's application for treatment of PsA and AS has been postponed for the second time
Time of Update: 2021-08-10
Pfizer's JAK inhibitor Xeljanz, in a post-marketing study for patients with rheumatoid arthritis, found dangerous cardiac side effects and additional risks of cancer, which caused the FDA to raise safety concerns about JAK inhibitor drugs .
-
Researchers reduced the severity of sleep apnea by at least 30%
Time of Update: 2021-08-09
A new study published in The Journal of Physiology shows that researchers have successfully reused two existing drugs to reduce the severity of sleep apnea by at least 30% .
-
The third domestic product! Nanjing Chia Tai Tianqing won 200 million antiemetic aprepitant capsules
Time of Update: 2021-08-09
Medical Network, July 5 News On July 1, the official website of the State Food and Drug Administration showed that Nanjing Chia Tai Tianqing’s aprepitant capsules were approved for production in generic 4 categories, which were deemed to have been reviewed .
-
Thermo Fisher launches a new extended gene therapy portfolio to support more effective adeno-associated virus preparation
Time of Update: 2021-08-08
Recently, Thermo Fisher Scientific has launched a set of solutions that support the production of adeno-associated virus (AAV) to help gene therapy developers quickly and efficiently scale production .
The new solution aimed at producing higher quality viral vectors simplifies the purification process, resulting in higher AAV yields .
-
2021 Cell Industry Conference 2021 7th (Shenzhen) Cell and Tumor Precision Medicine Summit Forum
Time of Update: 2021-08-08
The Cell Industry Conference has been successfully held for six sessions. After continuous exploration, development, accumulation and precipitation, it has grown into a major event in the domestic ce
